Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With Schizophrenia

Predictors of Relapse Following Response From a First Episode of Schizophrenia or Schizoaffective Disorder

Robinson, D., Woerner, M. G., Alvir, J. M. J., Bilder, R., Goldman, R., Geisler, S., Koreen, A., Sheitman, B., Chakos, M., Mayerhoff, D., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.3.241 · Cited by 1,327 · see citing works

The assessment of refill compliance using pharmacy records: Methods, validity, and applications

Steiner, J. F., & Prochazka, A. V. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00268-5 · Cited by 1,198 · see citing works

Assessing Quality Using Administrative Data

Iezzoni, L. I. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00048 · Cited by 981 · see citing works

Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical Findings

Fenton, W. S., Blyler, C. R., & HEINSSEN, R. K. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.4.637 · Cited by 944 · see citing works

Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice

Farmer, K. C. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(99)80026-5 · Cited by 889 · see citing works

Cost of Relapse in Schizophrenia

Weiden, P. J., & Olfson, M. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.3.419 · Cited by 665 · see citing works

Adherence to Treatment With Antipsychotic Medication and Health Care Costs Among Medicaid Beneficiaries With Schizophrenia

Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., & Jeste, D. V. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.692 · Cited by 603 · see citing works

Validation of Patient Reports, Automated Pharmacy Records, and Pill Counts With Electronic Monitoring of Adherence to Antihypertensive Therapy

Choo, P. W., Rand, C. S., Inui, T. S., Lee, M. T., Cain, E., Cordeiro-Breault, M., Canning, C. F., & Platt, R. G. (1999) · Medical Care · doi:10.1097/00005650-199909000-00002 · Cited by 546 · see citing works

A General Method of Compliance Assessment Using Centralized Pharmacy Records

Steiner, J. F., Koepsell, T. D., Fihn, S. D., & Inui, T. S. (1988) · Medical Care · doi:10.1097/00005650-198808000-00007 · Cited by 458 · see citing works

Pharmacy Data Identify Poorly Adherent Patients With Schizophrenia at Increased Risk for Admission

Valenstein, M. M., Copeland, L. A., Blow, F. C., McCarthy, J. F., Zeber, J. E., Gillon, L., Bingham, C. R., & Stavenger, T. (2002) · Medical Care · doi:10.1097/00005650-200208000-00002 · Cited by 339 · see citing works

Treatment for glaucoma: adherence by the elderly.

Gurwitz, J. H., Glynn, R. J., Monane, M., Everitt, D. E., Gilden, D., Smith, N., & Avorn, J. (1993) · American Journal of Public Health · doi:10.2105/ajph.83.5.711 · Cited by 267 · see citing works

Noncompliance With Congestive Heart Failure Therapy in the Elderly

Monane, M. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420040107014 · Cited by 266 · see citing works

Factors influencing relapse in the long-term course of schizophrenia

Ayuso-Gutiérrez, J. L., & Vega, J. M. D. R. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00131-x · Cited by 203 · see citing works

Medicaid data as a resource for epidemiologic studies: Strengths and limitations

Bright, R. A., Avorn, J., & Everitt, D. E. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90158-3 · Cited by 188 · see citing works

The Costs of Interrupting Antihypertensive Drug Therapy in a Medicaid Population

McCombs, J. S., Nichol, M. B., Newman, C. M., & Sclar, D. A. (1994) · Medical Care · doi:10.1097/00005650-199403000-00003 · Cited by 187 · see citing works

The ups and downs of oral lithium dosing.

Kilts, C. D. (1998) · PubMed · Cited by 117 · see citing works

Underutilization of Antihypertensive Drugs and Associated Hospitalization

Maronde, R. F., Chan, L. S., Larsen, F. J., Strandberg, L. R., Laventurier, M. F., & Sullivan, S. R. (1989) · Medical Care · doi:10.1097/00005650-198912000-00007 · Cited by 104 · see citing works

Compliance assessed by the Medication Event Monitoring System.

Olivieri, N. F., Matsui, D. M., Hermann, C., & Koren, G. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.12.1399 · Cited by 87 · see citing works

Effect of value–added utilities on prescription refill compliance and Medicaid health care expenditures–a study of patients with non–insulin–dependent diabetes mellitus

Skaer, T. L., Sclar, D. A., Markowski, D. J., & Won, J. K. H. (1993) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.1993.tb00591.x · Cited by 77 · see citing works

Prevention of relapse in chronic schizophrenic patients.

Hogarty, G. E. (1993) · PubMed · Cited by 71 · see citing works

Use patterns for antipsychotic medications in medicaid patients with schizophrenia.

McCombs, J. S., Nichol, M. B., Stimmel, G. L., Shi, J., & Smith, R. R. (1999) · PubMed · Cited by 60 · see citing works

Noncompliance with congestive heart failure therapy in the elderly

Monane, M. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.4.433 · Cited by 58 · see citing works

Gaps in Use of Antipsychotics After Discharge by First-Admission Patients With Schizophrenia, 1989 to 1996

Mojtabai, R., Lavelle, J., Gibson, P. J., Sohler, N., Craig, T., Carlson, G. A., & Bromet, E. J. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.3.337 · Cited by 53 · see citing works

Utility of a transdermal delivery system for antihypertensive therapy. Part 1

Sclar, D. A., Skaer, T. L., Chin, A., Okamoto, M. P., & Gill, M. A. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90063-4 · Cited by 41 · see citing works

Antipsychotic maintenance in schizophrenia: Partial compliance and clinical outcome

Docherty, J. P., Mahmoud, R. A., Grogg, A. L., et al. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)80455-3 · Cited by 33 · see citing works

Utility of a transdermal delivery system for antihypertensive therapy. Part 2

Sclar, D. A., Skaer, T. L., Chin, A., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90064-5 · Cited by 17 · see citing works

Blood level monitoring of antipsychotics and antidepressants.

Javaid, J. I., Janicak, P. G., & Holland, D. (1991) · PubMed · Cited by 4 · see citing works

Good and poor adherence: optimal cut-point for adherence measures using administrative claims data.

Karve, S., Cleves, M. A., Helm, M., Hudson, T. J., West, D. S., & Martin, B. C. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903126833 · Cited by 620 · see citing works

Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness

Velligan, D. I., Sajatovic, M., Hatch, A., Kramata, P., & Docherty, J. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s124658 · Cited by 333 · see citing works

Medication Adherence: A Review of the Literature and Implications for Clinical Practice

Julius, R. J., Novitsky, M. A., & Dubin, W. R. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000344917.43780.77 · Cited by 301 · see citing works

Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review

Olivares, J. M., Sermon, J., Hemels, M., & Schreiner, A. (2013) · Annals of General Psychiatry · doi:10.1186/1744-859x-12-32 · Cited by 270 · see citing works

Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview

Correll, C. U., Kim, E., Sliwa, J. K., Hamm, W., Gopal, S., Mathews, M., Venkatasubramanian, R., & Saklad, S. R. (2021) · CNS Drugs · doi:10.1007/s40263-020-00779-5 · Cited by 205 · see citing works

Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness

Llorca, P. M., Abbar, M., Courtet, P., Guillaume, S., Lancrenon, S., & Samalin, L. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-340 · Cited by 188 · see citing works

Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–A review of the past decade

Barkhof, E., Meijer, C. J., de Sonneville, L. M. J., Linszen, D. H., & de Haan, L. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.02.005 · Cited by 183 · see citing works

A Visual Guide to Expected Blood Levels of Long-Acting Injectable Risperidone in Clinical Practice

WILSON, W. H. (2004) · Journal of Psychiatric Practice · doi:10.1097/00131746-200411000-00009 · Cited by 180 · see citing works

Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies

Czobor, P., Van Dorn, R. A., Citrome, L., Kahn, R. S., Fleischhacker, W. W., & Volavka, J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.04.003 · Cited by 112 · see citing works

Clinical benefits and impact of early use of long‐acting injectable antipsychotics for schizophrenia

Stevens, G. L., Dawson, G., & Zummo, J. (2016) · Early Intervention in Psychiatry · doi:10.1111/eip.12278 · Cited by 109 · see citing works

Factors Associated with Medication Adherence among Patients with Schizophrenia in Mekelle, Northern Ethiopia

Eticha, T., Teklu, A., Ali, D., Solomon, G., & Alemayehu, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120560 · Cited by 103 · see citing works

Factors influencing medication adherence among patients with severe mental disorders from the perspective of mental health professionals

Deng, M., Zhai, S., Ouyang, X., Liu, Z., & Ross, B. (2022) · BMC Psychiatry · doi:10.1186/s12888-021-03681-6 · Cited by 75 · see citing works

Strategies for improving adherence to second generation antipsychotics in patients with schizophrenia by increasing ease of use

BURTON, S. C. (2005) · Journal of Psychiatric Practice · doi:10.1097/00131746-200511000-00003 · Cited by 68 · see citing works

Healthcare resource usage of schizophrenia patients initiating long-acting injectable antipsychotics vs oral

Offord, S., Wong, B., Mirski, D., Baker, R. A., & Lin, J. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2012.751025 · Cited by 62 · see citing works

Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and nurses

Geerts, P., Martinez, G., & Schreiner, A. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-58 · Cited by 48 · see citing works

Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model

Hard, M. L., Mills, R. J., Sadler, B. M., Wehr, A. Y., Weiden, P. J., & von Moltke, L. (2017) · CNS Drugs · doi:10.1007/s40263-017-0447-7 · Cited by 44 · see citing works

Urgent Psychiatric Services: A Scoping Review

Sunderji, N., de Bibiana, J. T., & Stergiopoulos, V. (2015) · The Canadian Journal of Psychiatry · doi:10.1177/070674371506000904 · Cited by 35 · see citing works

Use of a Web-Based Shared Decision-Making Program: Impact on Ongoing Treatment Engagement and Antipsychotic Adherence

Finnerty, M. T., Layman, D. M., Chen, Q., Leckman-Westin, E., Bermeo, N., Ng-Mak, D. S., Rajagopalan, K., & Hoagwood, K. E. (2018) · Psychiatric Services · doi:10.1176/appi.ps.201800130 · Cited by 28 · see citing works

Factors associated with complete discontinuation of medication among patients with schizophrenia in the year after hospital discharge

Zhou, Y., Rosenheck, R., Mohamed, S., Ning, Y., & He, H. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.01.036 · Cited by 23 · see citing works

Leverage, the Treatment Relationship, and Treatment Participation

McNiel, D. E., Gormley, B., & Binder, R. L. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201200368 · Cited by 21 · see citing works

Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia

Hard, M. L., Wehr, A. Y., Du, Y., Weiden, P. J., Walling, D., & von Moltke, L. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000921 · Cited by 17 · see citing works

Redefining Medication Adherence in the Treatment of Schizophrenia

Weiden, P. J. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2016.01.004 · Cited by 16 · see citing works

Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia

Morton, N. K., & Zubek, D. (2013) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20130215-01 · Cited by 16 · see citing works

Homelessness and Medicaid Churn

Dapkins, I. P., & Blecker, S. (2021) · Ethnicity & Disease · doi:10.18865/ed.31.1.89 · Cited by 12 · see citing works

Impacts of early ACA Medicaid expansions on physician participation

Curto, V. E., & Bhole, M. (2021) · Health Services Research · doi:10.1111/1475-6773.13925 · Cited by 10 · see citing works

Previous Medicaid Status of Children Newly Enrolled in Supplemental Security Income.

Perrin, J. M., Kuhlthau, K. A., Ettner, S. L., et al. (1998) · PubMed · Cited by 5 · see citing works

Medicaid Expansions and Access to Substance Abuse Treatment Services Among Limited English Proficiency Populations

Lee, D.-H., & Dugan, J. A. (2023) · Medical Care · doi:10.1097/mlr.0000000000001928 · Cited by 4 · see citing works

The Impact of Medicaid Expansion on Continuous Enrollment: a Two-State Analysis

Gordon, S. H., Sommers, B. D., Wilson, I. B., et al. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05101-8 · Cited by 18 · see citing works